TNF and rheumatoid arthritis: Similarly, another study done in France by Juillard-Condat and colleagues reported that after 1 month of using an anti-TNF-α antagonist, the average cost per patient with RA in the RA-related costs grew by 2.8-fold, and the medication costs per capita soared by 69.7% after 1 month of treatment[12].